Self-Assembly and Multifaceted Bioactivity of a Silver(I) Quinolinate Coordination Polymer
- PMID: 34546735
- PMCID: PMC8527454
- DOI: 10.1021/acs.inorgchem.1c02110
Self-Assembly and Multifaceted Bioactivity of a Silver(I) Quinolinate Coordination Polymer
Abstract
Coordination polymers have emerged as a new class of potent biologically active agents due to a variety of important characteristics such as the presence of bioactive metal centers and linkers, low toxicity, stability, tailorable structures, and bioavailability. The research on intermediate metabolites has also been explored with implications toward the development of selective anticancer, antimicrobial, and antiviral therapeutic strategies. In particular, quinolinic acid (H2quin) is a recognized metabolite in kynurenine pathway and potent neurotoxic molecule, which has been selected in this study as a bioactive building block for assembling a new silver(I) coordination polymer, [Ag(Hquin)(μ-PTA)]n·H2O (1). This product has been prepared from silver oxide, H2quin, and 1,3,5-triaza-7-phosphaadamantane (PTA), and fully characterized by standard methods including single-crystal X-ray diffraction. Compound 1 has revealed distinctive bioactive features, namely (i) a remarkable antiviral activity against herpes simplex virus type 1 (HSV-1) and adenovirus 36 (Ad-36), (ii) a significant antibacterial activity against clinically important bacteria (Staphylococcus aureus, Escherichia coli, and Pseudomonas aeruginosa), and (iii) a selective cytotoxicity against HeLa (human cervix carcinoma) cell line. The present work widens a growing family of bioactive coordination polymers with potent antiviral, antibacterial, and antiproliferative activity.
Conflict of interest statement
The authors declare no competing financial interest.
Figures





References
-
- de Paiva R. E. F.; Neto A. M.; Santos I. A.; Jardim A. C.G.; Carbi P. P.; Bergamini F. R.G. What is holding back the development of antiviral metallodrugs? A literature overview and implications for SARS-CoV-2 therapeutics and future viral outbreaks. Dalton. Trans. 2020, 49, 16004–16033. 10.1039/D0DT02478C. - DOI - PubMed
-
- Waye M. M. Y.; Sing C. W. Anti-Viral Drugs for Human Adenoviruses. Pharmaceuticals 2010, 3, 3343–3354. 10.3390/ph3103343. - DOI
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials